| Code | Name | Last | Change(%) | P/E | Yield (%) | P/E Range | ||
| PRGO | Perrigo Company PLC |  | 13.82 | +0.51% | 2,758 | 8.39 |  | |
| Pre Market | | 13.96 | +1.01% | |||||
| AMRX | Amneal Pharmaceuticals | | 12.95 | +0.62% | 1,287 | -- | | |
| Pre Market | | 13.01 | +0.46% | |||||
| ELAN | Elanco Animal Health | | 22.6 | +0.98% | 319.71 | -- | | |
| Pre Market | | 22.7 | +0.44% | |||||
| TAK | Takeda Pharmaceutical Company Limited | | 15.65 | +0.45% | 232.08 | 4.22 | | |
| Pre Market |  | 15.64 | -0.06% | |||||
| VTRS | Viatris | | 12.32 | +0.65% | 227.2 | 3.9 | | |
| Pre Market |  | 12.32 | 0.00% | |||||
| OGI | Organigram Global Inc | | 1.79 | +1.70% | 222.35 | -- | | |
| Pre Market | | 1.77 | -1.12% | |||||
| TXMD | TherapeuticsMD | | 1.74 | +2.35% | 167 | -- |  | |
| Pre Market | | 1.69 | -2.87% | |||||
| CTOR | Citius Oncology Inc | | 1.13 | -1.31% | 150 | -- | | |
| Pre Market | | 1.0704 | -5.27% | |||||
| ETON | Eton Pharmaceuticals | | 16.83 | -0.94% | 124 | -- | | |
| Pre Market | | 16.83 | 0.00% | |||||
| KNSA | Kiniksa Pharmaceuticals International plc | | 42 | -1.15% | 94 | -- | | |
| Pre Market | | 41.65 | -0.83% | |||||
| HIMS | Hims & Hers Health | | 34.31 | -1.04% | 65.13 | -- | | |
| Pre Market | | 33.8125 | -1.45% | |||||
| ORGO | Organogenesis Holdings | | 5.275 | -10.14% | 60.5 | -- | | |
| Pre Market | | 5.38 | +1.99% | |||||
| ZYBT | Zhengye Biotechnology Holding Limited | | 1.53 | -8.93% | 59.12 | -- | | |
| Pre Market | | 1.5109 | -1.25% | |||||
| LFCR | Lifecore Biomedical | | 8.3 | +0.61% | 55.38 | -- | | |
| Pre Market | | 8 | -3.61% | |||||
| PCRX | Pacira BioSciences | | 26.51 | +1.88% | 55.36 | -- | | |
| Pre Market | | 26.69 | +0.68% | |||||
| TEVA | Teva Pharmaceutical Industries Limited | | 31.89 | +0.47% | 52.21 | 0.27 | | |
| Pre Market | | 31.6 | -0.91% | |||||
| ANIP | ANI Pharmaceuticals | | 82.41 | +0.28% | 51.36 | -- |  | |
| Pre Market | | -- | -- | |||||
| DVAX | Dynavax Technologies Corp | | 15.38 | -- | 48.45 | -- | | |
| Pre Market | | 15.36 | -0.13% | |||||
| SUPN | Supernus Pharmaceuticals | | 51.57 | -0.39% | 40.02 | -- | | |
| Pre Market | | 51.74 | +0.33% | |||||
| DERM | Journey Medical Corp | | 7.92 | -2.58% | 39.69 | -- | | |
| Pre Market | | -- | -- | |||||
 | Quotes are at least 15-min delayed：2025/12/29 08:40 EDT |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |